230 related articles for article (PubMed ID: 30150462)
1. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
[TBL] [Abstract][Full Text] [Related]
3. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
Kunkel A; White M; Piola P
PLoS Comput Biol; 2021 Mar; 17(3):e1008850. PubMed ID: 33764971
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
[TBL] [Abstract][Full Text] [Related]
8. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
10.
Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249691
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
[TBL] [Abstract][Full Text] [Related]
12. High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
Warsame M; Hassan AM; Hassan AH; Jibril AM; Khim N; Arale AM; Gomey AH; Nur ZS; Osman SM; Mohamed MS; Abdulrahman A; Yusuf FE; Amran JGH; Witkowski B; Ringwald P
Malar J; 2019 Jul; 18(1):231. PubMed ID: 31296223
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Assefa A; Mohammed H; Anand A; Abera A; Sime H; Minta AA; Tadesse M; Tadesse Y; Girma S; Bekele W; Etana K; Alemayehu BH; Teka H; Dilu D; Haile M; Solomon H; Moriarty LF; Zhou Z; Svigel SS; Ezema B; Tasew G; Woyessa A; Hwang J; Murphy M
Malar J; 2022 Dec; 21(1):359. PubMed ID: 36451216
[TBL] [Abstract][Full Text] [Related]
15. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Dihydroartemisinin-Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam.
Tran THT; Hien BTT; Dung NTL; Huong NT; Binh TT; Van Long N; Ton ND
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929629
[No Abstract] [Full Text] [Related]
18. Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
Mohamed AO; Abdel Hamid MM; Mohamed OS; Elkando NS; Suliman A; Adam MA; Elnour FAA; Malik EM
Malar J; 2017 Apr; 16(1):163. PubMed ID: 28427409
[TBL] [Abstract][Full Text] [Related]
19. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
